cabozantinib and Foot-Dermatoses

cabozantinib has been researched along with Foot-Dermatoses* in 1 studies

Other Studies

1 other study(ies) available for cabozantinib and Foot-Dermatoses

Article	Year
Hand-foot skin reaction with primarily dorsal involvement in a patient with metastatic renal cell carcinoma on cabozantinib. Dermatology online journal, 2020, Aug-15, Volume: 26, Issue:8 A 61-year-old man with metastatic renal cell carcinoma on cabozantinib developed hand-foot skin reaction with predominantly dorsal involvement including painful violaceous plaques over the joints and keratotic yellow plaques on the palmar fingers. The medication was discontinued with resolution of the plaques and later reinitiated at a lower dose uneventfully. Topics: Anilides; Biopsy; Carcinoma, Renal Cell; Foot Dermatoses; Hand Dermatoses; Humans; Kidney Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Pyridines; Receptor Protein-Tyrosine Kinases; Skin	2020

Article

Year

Hand-foot skin reaction with primarily dorsal involvement in a patient with metastatic renal cell carcinoma on cabozantinib.

Dermatology online journal, 2020, Aug-15, Volume: 26, Issue:8

A 61-year-old man with metastatic renal cell carcinoma on cabozantinib developed hand-foot skin reaction with predominantly dorsal involvement including painful violaceous plaques over the joints and keratotic yellow plaques on the palmar fingers. The medication was discontinued with resolution of the plaques and later reinitiated at a lower dose uneventfully.

Topics: Anilides; Biopsy; Carcinoma, Renal Cell; Foot Dermatoses; Hand Dermatoses; Humans; Kidney Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Pyridines; Receptor Protein-Tyrosine Kinases; Skin

2020